Eli Lilly Strikes $1.1 Billion Deal With Seamless Therapeutics To Develop Gene Therapies For Hearing Loss Under the terms of the deal between Seamless Therapeutics and Eli Lilly, Seamless will design and program site-specific enzymes to correct mutations in certain genes related to hearing loss.
PYPL Stock Hit With A Downgrade As 'Marginal Consumer' Moves Away From Its Platform According to TheFly, analysts at Rothschild & Co Redburn downgraded PayPal to ‘Sell’ from ‘Neutral’ and lowered the price target to $50 from $70.
Tesla’s Talent Exodus: Fremont Factory Exec Benjamin Bate Leaves For Chemelex According to Bate’s Linkedin, he is now plant manager at Redwood-city-based electric thermal management and sensing solutions provider Chemelex.
Better S&P 500 ETF: iShares IVV vs. Vanguard VOO Subtle differences in dividend yield and sector tilt set these two S&P 500 giants apart for investors weighing their options.
What Autonomy Features Come Standard On New Tesla Vehicle Purchases Now That Autopilot Is No More? Previously, Tesla offered basic autopilot as a standard on new vehicle purchases, which included autosteer and traffic-aware cruise control.
Microsoft’s AI Data Center Growth Key For Azure’s Momentum, Says UBS UBS cited developments in Microsoft’s AI infrastructure deployments as a key driver of future cloud expansion.
The Smartest S&P 500 ETF to Buy With $100 Right Now Investors looking at the market today should probably err on the side of caution by opting to go with this unique S&P 500 ETF.
Where Will the Vanguard S&P 500 ETF Be in 1 Year? In the past 12 months, this popular ETF has produced a total return of 17%.
Cathie Wood Buys The Netflix Dip As Shares Slide On WBD Deal Jitters The noted tech investor bought over $7 million worth of NFLX shares, doubling down on her initial purchase in October.
Tesla Shareholders Eye Answers On SpaceX IPO At EV Giant’s Upcoming Q4 Earnings Call The top voted question for Tesla leadership pertains to whether Tesla shareholders will be prioritized in the event of a SpaceX IPO.
Lululemon Founder Pins Pullback Of Sheer Training Pants On Board’s Lack Of Experience, Calls It ‘A New Low’ Chip Wilson alleged on Wednesday that the company has “completely lost its way” as a technical apparel leader and that it has failed to deliver products that “work.”
Merck Shares Rise On $30M Funding From CEPI To Develop Affordable Ebola Vaccine CEPI will provide Merck with $30 million and Merck will, in turn, leverage its joint venture with Wellcome, called Hilleman Laboratories, to develop an Ebola vaccine with an updated manufacturing process.
1 No-Brainer S&P Index Fund to Buy Right Now for Less Than $200 A major dynamic that's led to some unusual market action of late could be on the verge of a sweeping reversal.
The Smartest Vanguard ETF to Buy With $500 Right Now Investing in the Vanguard S&P 500 ETF right now would be a smart move.
If History Repeats, This Unstoppable ETF Can Make You a Millionaire With a $100,000 Initial Investment and $655 Monthly Contributions Over 20 Years The widely followed index that this exchange-traded fund (ETF) mirrors hasn't had a negative annualized total return, including dividends, over any 20-year rolling period spanning more than a century.
Better Blue-Chip ETF: Vanguard's VOO vs. State Street's DIA Explore how differences in sector focus, diversification, and cost structure set these two blue-chip ETFs apart for investors.
This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it.
